 | • レポートコード：B-GIR09D3927 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、がんにおける薬物デリバリーの世界市場について調べ、まとめました。種類別セグメントは、リポソーム、PEG化タンパク質およびポリペプチド、ポリマーナノ粒子、タンパク質-薬物コンジュゲート、その他等、用途別セグメントは、病院・診療所、がん治療センター、その他等に区分しました。がんにおける薬物デリバリーの世界市場概観、企業動向、企業別がんにおける薬物デリバリーシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・がんにおける薬物デリバリーの市場概観 ・がんにおける薬物デリバリーの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・がんにおける薬物デリバリーの企業別販売動向、市場シェア、市場集中度、競争動向 ・がんにおける薬物デリバリーの世界市場規模 ・がんにおける薬物デリバリーの北米市場分析（アメリカ、カナダ、メキシコ等） ・がんにおける薬物デリバリーのアメリカ市場規模推移 ・がんにおける薬物デリバリーのカナダ市場規模推移 ・がんにおける薬物デリバリーのメキシコ市場規模推移 ・がんにおける薬物デリバリーのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・がんにおける薬物デリバリーのドイツ市場規模推移 ・がんにおける薬物デリバリーのイギリス市場規模推移 ・がんにおける薬物デリバリーのロシア市場規模推移 ・がんにおける薬物デリバリーのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・がんにおける薬物デリバリーの日本市場規模推移 ・がんにおける薬物デリバリーの中国市場規模推移 ・がんにおける薬物デリバリーの韓国市場規模推移 ・がんにおける薬物デリバリーのインド市場規模推移 ・がんにおける薬物デリバリーの東南アジア市場規模推移 ・がんにおける薬物デリバリーの南米市場分析（ブラジル、アルゼンチン等） ・がんにおける薬物デリバリーの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・がんにおける薬物デリバリーの種類別分析/販売量、売上、市場シェア（リポソーム、PEG化タンパク質およびポリペプチド、ポリマーナノ粒子、タンパク質-薬物コンジュゲート、その他） ・がんにおける薬物デリバリーの用途別分析/市場規模（病院・診療所、がん治療センター、その他） ・がんにおける薬物デリバリーの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・がんにおける薬物デリバリーの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Drug Delivery in Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Drug Delivery in Cancer.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Drug Delivery in Cancer market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Drug Delivery in Cancer market by product type and applications/end industries.
Market Segment by Companies, this report covers
Amgen
Teva
UCB (Union Chimique Belge)
Roche
Celgene
Sanofi
Merck
Johnson & Johnson
Takeda
Gilead Sciences
Pfizer
Dr Reddy
Samyang Biopharmaceuticals
Tolmar
Astellas
AMAG Pharmaceuticals
AstraZeneca
AbbVie
Novartis
Aspen
Shire (Baxalta)
Breckenridge Pharmaceuticals
Galen Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein–drug Conjugates
Others
Market Segment by Applications, can be divided into
Hospitals & Clinic
Cancer Treatment Centers
Others
Table of Contents
1 Drug Delivery in Cancer Market Overview
1.1 Product Overview and Scope of Drug Delivery in Cancer
1.2 Classification of Drug Delivery in Cancer by Types
1.2.1 Global Drug Delivery in Cancer Revenue Comparison by Types (2019-2024)
1.2.2 Global Drug Delivery in Cancer Revenue Market Share by Types in 2018
1.2.3 Liposomes
1.2.4 PEGylated Proteins & Polypeptides
1.2.5 Polymer Nanoparticle
1.2.6 Protein–drug Conjugates
1.2.7 Others
1.3 Global Drug Delivery in Cancer Market by Application
1.3.1 Global Drug Delivery in Cancer Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals & Clinic
1.3.3 Cancer Treatment Centers
1.3.4 Others
1.4 Global Drug Delivery in Cancer Market by Regions
1.4.1 Global Drug Delivery in Cancer Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Drug Delivery in Cancer Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Drug Delivery in Cancer Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Drug Delivery in Cancer Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Drug Delivery in Cancer Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Drug Delivery in Cancer Status and Prospect (2014-2024)
1.5 Global Market Size of Drug Delivery in Cancer (2014-2024)
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.2 Drug Delivery in Cancer Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.2 Teva
2.2.1 Business Overview
2.2.2 Drug Delivery in Cancer Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Teva Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.3 UCB (Union Chimique Belge)
2.3.1 Business Overview
2.3.2 Drug Delivery in Cancer Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 UCB (Union Chimique Belge) Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.4 Roche
2.4.1 Business Overview
2.4.2 Drug Delivery in Cancer Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Roche Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.5 Celgene
2.5.1 Business Overview
2.5.2 Drug Delivery in Cancer Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Celgene Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.6 Sanofi
2.6.1 Business Overview
2.6.2 Drug Delivery in Cancer Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sanofi Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.7 Merck
2.7.1 Business Overview
2.7.2 Drug Delivery in Cancer Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.8 Johnson & Johnson
2.8.1 Business Overview
2.8.2 Drug Delivery in Cancer Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Johnson & Johnson Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.9 Takeda
2.9.1 Business Overview
2.9.2 Drug Delivery in Cancer Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Takeda Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.10 Gilead Sciences
2.10.1 Business Overview
2.10.2 Drug Delivery in Cancer Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Gilead Sciences Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.11 Pfizer
2.11.1 Business Overview
2.11.2 Drug Delivery in Cancer Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Pfizer Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.12 Dr Reddy
2.12.1 Business Overview
2.12.2 Drug Delivery in Cancer Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Dr Reddy Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.13 Samyang Biopharmaceuticals
2.13.1 Business Overview
2.13.2 Drug Delivery in Cancer Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Samyang Biopharmaceuticals Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.14 Tolmar
2.14.1 Business Overview
2.14.2 Drug Delivery in Cancer Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Tolmar Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.15 Astellas
2.15.1 Business Overview
2.15.2 Drug Delivery in Cancer Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Astellas Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.16 AMAG Pharmaceuticals
2.16.1 Business Overview
2.16.2 Drug Delivery in Cancer Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 AMAG Pharmaceuticals Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.17 AstraZeneca
2.17.1 Business Overview
2.17.2 Drug Delivery in Cancer Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 AstraZeneca Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.18 AbbVie
2.18.1 Business Overview
2.18.2 Drug Delivery in Cancer Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 AbbVie Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.19 Novartis
2.19.1 Business Overview
2.19.2 Drug Delivery in Cancer Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Novartis Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.20 Aspen
2.20.1 Business Overview
2.20.2 Drug Delivery in Cancer Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Aspen Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.21 Shire (Baxalta)
2.21.1 Business Overview
2.2.2 Drug Delivery in Cancer Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Shire (Baxalta) Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.22 Breckenridge Pharmaceuticals
2.22.1 Business Overview
2.22.2 Drug Delivery in Cancer Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Breckenridge Pharmaceuticals Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.23 Galen Pharmaceuticals
2.23.1 Business Overview
2.23.2 Drug Delivery in Cancer Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Galen Pharmaceuticals Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
3 Global Drug Delivery in Cancer Market Competition, by Players
3.1 Global Drug Delivery in Cancer Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Drug Delivery in Cancer Players Market Share
3.2.2 Top 10 Drug Delivery in Cancer Players Market Share
3.3 Market Competition Trend
4 Global Drug Delivery in Cancer Market Size by Regions
4.1 Global Drug Delivery in Cancer Revenue and Market Share by Regions
4.2 North America Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
4.3 Europe Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
4.5 South America Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
5 North America Drug Delivery in Cancer Revenue by Countries
5.1 North America Drug Delivery in Cancer Revenue by Countries (2014-2019)
5.2 USA Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
5.3 Canada Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
5.4 Mexico Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
6 Europe Drug Delivery in Cancer Revenue by Countries
6.1 Europe Drug Delivery in Cancer Revenue by Countries (2014-2019)
6.2 Germany Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
6.3 UK Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
6.4 France Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
6.5 Russia Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
6.6 Italy Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Drug Delivery in Cancer Revenue by Countries
7.1 Asia-Pacific Drug Delivery in Cancer Revenue by Countries (2014-2019)
7.2 China Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
7.3 Japan Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
7.4 Korea Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
7.5 India Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
8 South America Drug Delivery in Cancer Revenue by Countries
8.1 South America Drug Delivery in Cancer Revenue by Countries (2014-2019)
8.2 Brazil Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
8.3 Argentina Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
8.4 Colombia Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Drug Delivery in Cancer by Countries
9.1 Middle East and Africa Drug Delivery in Cancer Revenue by Countries (2014-2019)
9.2 Saudi Arabia Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
9.3 UAE Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
9.4 Egypt Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
9.5 Nigeria Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
9.6 South Africa Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
10 Global Drug Delivery in Cancer Market Segment by Type
10.1 Global Drug Delivery in Cancer Revenue and Market Share by Type (2014-2019)
10.2 Global Drug Delivery in Cancer Market Forecast by Type (2019-2024)
10.3 Liposomes Revenue Growth Rate (2014-2024)
10.4 PEGylated Proteins & Polypeptides Revenue Growth Rate (2014-2024)
10.5 Polymer Nanoparticle Revenue Growth Rate (2014-2024)
10.6 Protein–drug Conjugates Revenue Growth Rate (2014-2024)
10.7 Others Revenue Growth Rate (2014-2024)
11 Global Drug Delivery in Cancer Market Segment by Application
11.1 Global Drug Delivery in Cancer Revenue Market Share by Application (2014-2019)
11.2 Drug Delivery in Cancer Market Forecast by Application (2019-2024)
11.3 Hospitals & Clinic Revenue Growth (2014-2019)
11.4 Cancer Treatment Centers Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Drug Delivery in Cancer Market Size Forecast (2019-2024)
12.1 Global Drug Delivery in Cancer Market Size Forecast (2019-2024)
12.2 Global Drug Delivery in Cancer Market Forecast by Regions (2019-2024)
12.3 North America Drug Delivery in Cancer Revenue Market Forecast (2019-2024)
12.4 Europe Drug Delivery in Cancer Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Drug Delivery in Cancer Revenue Market Forecast (2019-2024)
12.6 South America Drug Delivery in Cancer Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Drug Delivery in Cancer Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Drug Delivery in Cancer Picture
Table Product Specifications of Drug Delivery in Cancer
Table Global Drug Delivery in Cancer and Revenue (Million USD) Market Split by Product Type
Figure Global Drug Delivery in Cancer Revenue Market Share by Types in 2018
Figure Liposomes Picture
Figure PEGylated Proteins & Polypeptides Picture
Figure Polymer Nanoparticle Picture
Figure Protein–drug Conjugates Picture
Figure Others Picture
Table Global Drug Delivery in Cancer Revenue (Million USD) by Application (2014-2024)
Figure Drug Delivery in Cancer Revenue Market Share by Applications in 2018
Figure Hospitals & Clinic Picture
Figure Cancer Treatment Centers Picture
Figure Others Picture
Table Global Market Drug Delivery in Cancer Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Drug Delivery in Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Drug Delivery in Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Drug Delivery in Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Drug Delivery in Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Drug Delivery in Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Drug Delivery in Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Drug Delivery in Cancer Type and Applications
Table Amgen Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Drug Delivery in Cancer Type and Applications
Table Teva Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table UCB (Union Chimique Belge) Basic Information, Manufacturing Base and Competitors
Table UCB (Union Chimique Belge) Drug Delivery in Cancer Type and Applications
Table UCB (Union Chimique Belge) Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Drug Delivery in Cancer Type and Applications
Table Roche Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Drug Delivery in Cancer Type and Applications
Table Celgene Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Drug Delivery in Cancer Type and Applications
Table Sanofi Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Drug Delivery in Cancer Type and Applications
Table Merck Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Drug Delivery in Cancer Type and Applications
Table Johnson & Johnson Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Drug Delivery in Cancer Type and Applications
Table Takeda Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table Gilead Sciences Drug Delivery in Cancer Type and Applications
Table Gilead Sciences Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Drug Delivery in Cancer Type and Applications
Table Pfizer Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Dr Reddy Basic Information, Manufacturing Base and Competitors
Table Dr Reddy Drug Delivery in Cancer Type and Applications
Table Dr Reddy Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Samyang Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Samyang Biopharmaceuticals Drug Delivery in Cancer Type and Applications
Table Samyang Biopharmaceuticals Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Tolmar Basic Information, Manufacturing Base and Competitors
Table Tolmar Drug Delivery in Cancer Type and Applications
Table Tolmar Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Astellas Basic Information, Manufacturing Base and Competitors
Table Astellas Drug Delivery in Cancer Type and Applications
Table Astellas Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table AMAG Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table AMAG Pharmaceuticals Drug Delivery in Cancer Type and Applications
Table AMAG Pharmaceuticals Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Drug Delivery in Cancer Type and Applications
Table AstraZeneca Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Drug Delivery in Cancer Type and Applications
Table AbbVie Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Drug Delivery in Cancer Type and Applications
Table Novartis Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Aspen Basic Information, Manufacturing Base and Competitors
Table Aspen Drug Delivery in Cancer Type and Applications
Table Aspen Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Shire (Baxalta) Basic Information, Manufacturing Base and Competitors
Table Shire (Baxalta) Drug Delivery in Cancer Type and Applications
Table Shire (Baxalta) Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Breckenridge Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Breckenridge Pharmaceuticals Drug Delivery in Cancer Type and Applications
Table Breckenridge Pharmaceuticals Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Galen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Galen Pharmaceuticals Drug Delivery in Cancer Type and Applications
Table Galen Pharmaceuticals Drug Delivery in Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Global Drug Delivery in Cancer Revenue (Million USD) by Players (2014-2019)
Table Global Drug Delivery in Cancer Revenue Share by Players (2014-2019)
Figure Global Drug Delivery in Cancer Revenue Share by Players in 2017
Figure Global Drug Delivery in Cancer Revenue Share by Players in 2018
Figure Global Top 5 Players Drug Delivery in Cancer Revenue Market Share in 2018
Figure Global Top 10 Players Drug Delivery in Cancer Revenue Market Share in 2018
Figure Global Drug Delivery in Cancer Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Drug Delivery in Cancer Revenue (Million USD) by Regions (2014-2019)
Table Global Drug Delivery in Cancer Revenue Market Share by Regions (2014-2019)
Figure Global Drug Delivery in Cancer Revenue Market Share by Regions (2014-2019)
Figure Global Drug Delivery in Cancer Revenue Market Share by Regions in 2018
Figure North America Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Figure Europe Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Figure South America Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Table North America Drug Delivery in Cancer Revenue by Countries (2014-2019)
Table North America Drug Delivery in Cancer Revenue Market Share by Countries (2014-2019)
Figure North America Drug Delivery in Cancer Revenue Market Share by Countries (2014-2019)
Figure North America Drug Delivery in Cancer Revenue Market Share by Countries in 2018
Figure USA Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Figure Canada Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Figure Mexico Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Table Europe Drug Delivery in Cancer Revenue (Million USD) by Countries (2014-2019)
Figure Europe Drug Delivery in Cancer Revenue Market Share by Countries (2014-2019)
Figure Europe Drug Delivery in Cancer Revenue Market Share by Countries in 2018
Figure Germany Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Figure UK Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Figure France Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Figure Russia Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Figure Italy Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Drug Delivery in Cancer Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Drug Delivery in Cancer Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Drug Delivery in Cancer Revenue Market Share by Countries in 2018
Figure China Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Figure Japan Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Figure Korea Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Figure India Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Table South America Drug Delivery in Cancer Revenue by Countries (2014-2019)
Table South America Drug Delivery in Cancer Revenue Market Share by Countries (2014-2019)
Figure South America Drug Delivery in Cancer Revenue Market Share by Countries (2014-2019)
Figure South America Drug Delivery in Cancer Revenue Market Share by Countries in 2018
Figure Brazil Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Figure Argentina Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Figure Colombia Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Drug Delivery in Cancer Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Drug Delivery in Cancer Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Drug Delivery in Cancer Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Drug Delivery in Cancer Revenue Market Share by Countries in 2018
Figure Saudi Arabia Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Figure UAE Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Figure Egypt Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Figure Nigeria Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Figure South Africa Drug Delivery in Cancer Revenue and Growth Rate (2014-2019)
Table Global Drug Delivery in Cancer Revenue (Million USD) by Type (2014-2019)
Table Global Drug Delivery in Cancer Revenue Share by Type (2014-2019)
Figure Global Drug Delivery in Cancer Revenue Share by Type (2014-2019)
Figure Global Drug Delivery in Cancer Revenue Share by Type in 2019
Table Global Drug Delivery in Cancer Revenue Forecast by Type (2019-2024)
Figure Global Drug Delivery in Cancer Market Share Forecast by Type (2019-2024)
Figure Global Liposomes Revenue Growth Rate (2014-2019)
Figure Global PEGylated Proteins & Polypeptides Revenue Growth Rate (2014-2019)
Figure Global Polymer Nanoparticle Revenue Growth Rate (2014-2019)
Figure Global Protein–drug Conjugates Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Drug Delivery in Cancer Revenue by Application (2014-2019)
Table Global Drug Delivery in Cancer Revenue Share by Application (2014-2019)
Figure Global Drug Delivery in Cancer Revenue Share by Application (2014-2019)
Figure Global Drug Delivery in Cancer Revenue Share by Application in 2019
Table Global Drug Delivery in Cancer Revenue Forecast by Application (2019-2024)
Figure Global Drug Delivery in Cancer Market Share Forecast by Application (2019-2024)
Figure Global Hospitals & Clinic Revenue Growth Rate (2014-2019)
Figure Global Cancer Treatment Centers Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Drug Delivery in Cancer Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Drug Delivery in Cancer Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Drug Delivery in Cancer Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Drug Delivery in Cancer Revenue Market Forecast (2019-2024)
Figure Europe Drug Delivery in Cancer Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Drug Delivery in Cancer Revenue Market Forecast (2019-2024)
Figure South America Drug Delivery in Cancer Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Drug Delivery in Cancer Revenue Market Forecast (2019-2024)
世界の癌治療における新薬デリバリーシステム市場予測（～2024年） Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. …- 世界の医薬品ドラッグデリバリー市場予測（～2024年） Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect Scope of the Report: The worldwide market for Pharmaceutical Drug Delivery is expected to grow at a CAGR of ro…
- 世界の医薬品ドラッグデリバリー装置市場予測（～2024年） Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect Scope of the Report: The worldwide market for Pharmaceutical Drug Delivery Devices is expected to grow at a CA…
- 世界の医薬品ドラッグデリバリーテクノロジー市場予測（～2024年） Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect Scope of the Report: The worldwide market for Pharmaceutical Drug Delivery Technologies is expected to grow at…
- 世界の経皮/経粘膜ドラッグデリバリーシステム市場予測（～2024年） Transdermal/transmucosal drug delivery is a well-established accepted route of administration for therapeutically beneficial medicines. Transdermal/transmucosal drug delivery continues to play an important role in the development of a variety of therapeutic areas in both brand and generic products. …